Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study

Ratziu, V; Sanyal, A; Harrison, SA; Wong, VWS; Francque, S; Goodman, Z; Aithal, GP; Kowdley, KV; Seyedkazemi, S; Fischer, L; Loomba, R; Abdelmalek, MF; Tacke, F

Tacke, F (corresponding author), Charite Univ Med Berlin, Dept Gastroenterol & Hepatol, Augustenburger Pl 1, D-13353 Berlin, Germany.

HEPATOLOGY, 2020; 72 (3): 892

Abstract

Background and Aims Cenicriviroc (CVC) is a C-C chemokine receptors type 2 and 5 dual antagonist under evaluation for treating liver fibrosis in adult......

Full Text Link